News

Search For News


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Search results for {{term}}

1. Amgen Announces Results From Several New Exploratory Analyses Evaluati

Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia (Denosumab) In Postmenopausal Women WithOsteoporosis  Date: 16/09/2014Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels:UCB)  announced results from several exploratory analyses of the Phase 2 study evaluating romosozumab in postmenopausal women with low bone mineral density (BMD). Romosozumab is an investigational bone-forming agent that is designed to work by i


2. Google Buys Lift Labs in Further Biotech Push

Google Buys Lift Labs in Further Biotech Push Date: 18/09/2014A person could be forgiven for thinking that Google is a biotech company.Google plans to announce on Wednesday that it has bought Lift Labs, a San Francisco company that makes a high-tech spoon designed to make it easier for people with neurodegenerative tremors to eat, the latest in a growing list of moves the search giant has made into biotech.A Google representative said Lift Labs would be integrated into Google Life Sciences,


3.  Horizon Discovery Group plc Acquires Sage Labs Inc. for M (£29M)

 Horizon Discovery Group plc Acquires Sage Labs Inc. for $48M (£29M) Date:30/09/2014 Horizon Discovery Group plc (LSE: HZD) (“Horizon” or the “Company”), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, today announced it has agreed to acquire Sage Labs Inc. (Sage) for up to $16M (£9.8M) in cash and up to $32M (£19.6M) through t


4. Oxford BioMedica announces new process development and manufacturing c

Oxford BioMedica announces new process development and manufacturing collaboration which includes LentiVector licenceagreement  Date: 10/10/2014Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Group”) a leading gene and cell therapy company, announces today that it has signed further contracts with Novartis which build on the collaboration with Novartis announced in May 2013. Under the terms of the new agreement, Novartis will pay $14 million upfront including a $4.3


5. £5M for agricultural innovation

£5M for agricultural innovation Date: 23/10/2014Businesses and universities across the UK will benefit from a share of £5M of funding from government and industry.Businesses and universities across the UK will benefit from a share of £5M of funding from government and industry to develop innovations to solve some of the world's greatest agricultural challenges such as food security and sustainability, weed control and livestock disease.This £5M is part of the second roun



Page 1 of 30 ( 148 results in total )
© Catalyst Innovation Portal 2018